Written question asked by James Wild (Conservative) on Tuesday, 7 July 2026, in the House of Commons. It was due for an answer on Thursday, 9 July 2026. It was answered by Preet Kaur Gill (Labour) on Wednesday, 15 July 2026 on behalf of the Department of Health and Social Care.
Breast Cancer: Drugs
- Question
-
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with AstraZeneca and Diiachi Sankyo on making Enhertu breast cancer drugs viable for introduction to the NHS.
- Answer
-
I refer the hon. Member to the answer I gave to the hon. Member for South Basildon and East Thurrock on 29 June 2026 to Question 11564.
Secondary information
- Type
- Written question
- Reference
- 16588
- Session
- 2026-27
- Grouped for answer
- Yes
- Subjects
- Breast cancer Drugs NHS Trastuzumab deruxtecan
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-07-15 11:16:19 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/16588
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/16588
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/16588